The evolution of proton beam therapy: Current and future status.

about

The evolution of proton beam therapy: Current and future status.

Item

http://www.wikidata.org/entity/Q49333936

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The evolution of proton beam therapy: Current and future status.

@en

The evolution of proton beam therapy: Current and future status.

@nl

type

Item

label

The evolution of proton beam therapy: Current and future status.

@en

The evolution of proton beam therapy: Current and future status.

@nl

prefLabel

The evolution of proton beam therapy: Current and future status.

@en

The evolution of proton beam therapy: Current and future status.

@nl

P1476

The evolution of proton beam therapy: Current and future status.

@en

P2093

Jian Cheng

http://www.w3.org/2001/XMLSchema#string

Jiandong Zhang

http://www.w3.org/2001/XMLSchema#string

Kun Liu

http://www.w3.org/2001/XMLSchema#string

Xiufang Tian

http://www.w3.org/2001/XMLSchema#string

Yong Hou

http://www.w3.org/2001/XMLSchema#string

P2860

A Literature Survey on Cost-Effectiveness of Proton Beam Therapy in the Management of Breast Cancer Patients

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).

National trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base study.

High-dose concurrent chemo-proton therapy for Stage III NSCLC: preliminary results of a Phase II study

Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117.

Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer.

High-dose proton beam therapy for sinonasal mucosal malignant melanoma.

Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams.

Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.

P304

15-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MCO.2017.1499

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29399346

http://www.w3.org/2001/XMLSchema#string

P932

5772792

http://www.w3.org/2001/XMLSchema#string